PROCEPT BioRobotics Corporation (PRCT) Balance Sheet

The sequential decline in total assets and cash, despite revenue growth, suggests that the company is burning through its balance sheet to sustain expansion. The equity base also contracted from $402.2M to $340.1M over the same period, driven by cumulative net losses. This trajectory implies that without a path to profitability, the company may need to raise additional capital, potentially diluting existing shareholders.

The debt level has been stable around $78-81M over the past ten quarters, suggesting that the company is not relying heavily on debt to fund its operations. The D/E ratio has improved as equity grew, but the recent decline in equity may reverse this trend. Given the negative operating margins, the fixed debt service could become a burden if cash flows do not improve, though the current low leverage provides some cushion.

The minimal goodwill and relatively low PP&E suggest that PRCT's value lies in its intellectual property and commercial infrastructure rather than physical assets. The slight decline in PP&E from $48.4M in 2024Q1 to $48.6M in 2026Q2, despite growth, implies that the company is not capital-intensive, which is consistent with its low capex. This asset-light structure reduces depreciation drag but also means that the company's competitive advantage is intangible and may be harder to sustain.

The growing negative retained earnings highlight that the company has not yet achieved profitability, and its equity base is being supported by external capital infusions. The absence of share repurchases or dividends, as noted in the cash flow analysis, suggests that all capital is being reinvested. However, the significant stock-based compensation, which nearly equals the net loss, indicates that a portion of the equity is being used to compensate employees, potentially diluting existing shareholders over time.

The current ratio remains robust, indicating that short-term obligations are well covered by current assets. However, the declining trend suggests that liquidity is being consumed. With an operating cash burn of -$57.4M in 2026Q2, the cash position provides a substantial buffer, but the accelerating burn rate, as highlighted in the cash flow analysis, could shorten this runway if not reversed. Investors should monitor whether the company can achieve cash flow break-even before the cash cushion is depleted.